WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
Category: #headlines  By Pranali Mehta  Date: 2021-02-17
  • share
  • Twitter
  • Facebook
  • LinkedIn
WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
  • AstraZeneca COVID-19 vaccine has received approval in over 50 countries.
  • AstraZeneca vaccine is the second to be issued by the UN health agency, with Pfizer-BioNTech being the first.

Shares of AstraZeneca plc soared by 6% after the World Health Organization (WHO) reportedly granted a EUA (emergency use authorization) to its COVID-19 vaccine. This move could enable partners of the UN agency to ship millions of doses to economies as part of its global initiative to control the ongoing Coronavirus pandemic.

WHO stated that it would clear the British-Swedish multinational pharmaceutical company vaccines which are being developed by South Korea’s AstraZeneca-SKBio and the Serum Institute of India.

WHO’s declaration is expected to prompt the distribution of hundreds of millions of doses to economies that have joined the UN-backed COVAX initiative aimed at providing vaccines to the most vulnerable people in the world.

It is worth noting that the AstraZeneca vaccine has already been approved in over 50 countries, including Mexico, Argentina, India, and Britain. It is an inexpensive and simple dose to manage as compared to the Pfizer-BioNTech vaccine, which requires deep-cold storage, which is not common in many developing nations, sources claimed.

The use of the AstraZeneca COVID-19 vaccine was recommended by WHO experts, especially for people over the age of 18 years as well as in countries that have found COVID-19 variants.

Sources confirmed that post this development, the shares of the India unit of AstraZeneca Pharma increased by 9.7% to reach a high of USD 54.70 (Rs 3,985) on BSE (Bombay Stock Exchange).

After the Pfizer-BioNTech vaccine was approved in December by the WHO, the AstraZeneca vaccine is just the second approval given by the UN Health Agency.

Meanwhile, Australia has recently approved AstraZeneca’s COVID-19 vaccine and has requested around 53.8 million doses.

Source Credit –

https://economictimes.indiatimes.com/markets/stocks/news/astrazeneca-pharma-surges-10-as-who-okays-covid-vaccine-for-emergency-use/articleshow/80963175.cms

 

 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Hyundai joins forces with digital media consulting firm MegazoneCloud
Hyundai joins forces with digital media consulting firm MegazoneCloud
By Pranali Mehta

Hyundai Motor Company, a multinational automotive manufacturer, is reportedly collaborating with MegazoneCloud, a South Korean cloud management service provider, to introduce a media service platform called ‘Channel Hyundai’ to deliver a ...

The much-awaited successor to Nintendo Switch to arrive in late-2021
The much-awaited successor to Nintendo Switch to arrive in late-2021
By Pranali Mehta

According to reliable sources, the follow-up to Nintendo’s wildly successful handheld gaming console, Nintendo Switch, is expected to launch in 2021 post a three-year wait after the original device was released back in 2017. The Nintendo Switc...

Cargill launches ‘SeaFurther’ program to support seafood sustainability
Cargill launches ‘SeaFurther’ program to support seafood sustainability
By Pranali Mehta

Cargill- a leading American food corporation has reportedly launched the SeaFurther Sustainability initiative in a bid to help aqua farmers to increase the amount of sustainable seafood that renders less environmental impact. Notably, the initiative...